These techniques rely on labeled probes that recognize molecular alterations in human cells including radio-labeled HER2 antibodies, or PSMA detection, allowing radiologists to generate a molecular map of the tumor heterogeneity in real time112–114. This evidence concerns the gene ERBB2 and neoplasm.